Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

C. Chua, Terence; Moran, Brendan; H. Sugarbaker, Paul; A. Levine, Edward; Gléhen, Olivier; Noël Gilly, François; Baratti, Dario; Deraco, Marcello; Élias, Dominique; Sardi, Armando; Liauw, Winston; D. Yan, Tristan; Barrios, Pedro; Gómez Portilla, Alberto; H. J. T. de Hingh, Ignace; Ceelen, Wim; Pelz, Joerg; Piso, Pompiliu; González‐Moreno, Santiago; Van der Speeten, Kurt; L. Morris, David

doi:10.1200/jco.2011.39.7166

Public

Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Published in Journal of Clinical Oncology • May 22, 2012

Authors:

Terence C. Chua

Brendan Moran

Paul H. Sugarbaker

Abstract

PURPOSE: Pseudomyxoma peritonei (PMP) originating from an appendiceal mucinous neoplasm remains a biologically heterogeneous disease. The purpose of our study was to evaluate outcome and long-term survival after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) consol...

Subject

Medicine

Pseudomyxoma peritonei

Hyperthermic intraperitoneal chemotherapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!